ArticleBMJ case reports2021

Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.

Roberto Ovilla-Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.